Advertisement

Rheumatology International

, Volume 39, Issue 7, pp 1241–1248 | Cite as

Pain and gastrointestinal dysfunction are significant associations with psychiatric disorders in patients with Ehlers–Danlos syndrome and hypermobility spectrum disorders: a retrospective study

  • S. Wasim
  • J. S. Suddaby
  • M. Parikh
  • S. Leylachian
  • B. Ho
  • A. Guerin
  • J. SoEmail author
Comorbidities

Abstract

In this retrospective study, we investigate the frequency and types of psychiatric disorders and their relationship to systemic manifestations in a cohort of 391 Ehlers–Danlos syndromes (EDS) and hypermobility spectrum disorder (HSD) patients based on the current 2017 International Classification of EDS diagnostic criteria. A detailed, systematic retrospective chart review was undertaken for patients assessed for HSD or EDS at two Canadian health centres. Patients were diagnosed according to the Villefranche criteria and reclassified for this study according to the 2017 International Classification of EDS. Data validation and statistical analyses were conducted. Psychiatric disorders were very common, with 49.4% of the total cohort affected; 28.9% reported multiple psychiatric diagnoses. Mood (34.5%) and somatoform (28.6%) disorders were most common. Interestingly, attention-deficit/hyperactivity disorder (ADHD) was significantly enriched in the HSD, but not EDS cohort (p = 0.0002, 95% CI 3.48–9.00) compared to the general population. There were no differences in the systemic associations with having psychiatric manifestations in the HSD compared to the EDS subsets. Muscle/body pain (OR 1.99) and gastrointestinal dysfunction (OR 2.07) were significantly associated with having mood disorders, and gastrointestinal dysfunction (OR 2.61) and nerve-related pain (OR 3.27) were associated with having somatoform disorders across the cohort. The common systemic associations with the presence of psychiatric manifestations in both HSD and EDS reaffirm that the conditions should be treated as a spectrum rather than as wholly separate entities, particularly with respect to psychiatric management. EDS and HSD patients share common psychiatric presentations, though ADHD is more common with HSD.

Keywords

Genetics Rheumatology Psychiatry Pain Gastrointestinal diseases 

Notes

Acknowledgements

We acknowledge Dorsa Sohaei for assisting with data collection.

Author contributions

SW contributed to study design, data analysis and interpretation, and revision of the work. JSS contributed to data interpretation, and drafting and revision of the work. MP contributed to data acquisition, and drafting and revision of the work. SL, BH and AG contributed to data acquisition and revision of the work. JS contributed to study conception and design, data acquisition and interpretation, and drafting and revision of the work. All authors gave final approval of the version to be published and agree to be accountable for all aspects of the work.

Funding

The authors declare that this work was not supported by any grant or funding.

Compliance with ethical standards

Conflict of interest

All authors declare no conflicts of interest.

Ethical approval

Ethics approval for this study was obtained from University Health Network (Research Ethics Board (REB) #: 16-5634; date of approval: July 22, 2016), Mount Sinai Hospital (REB #: 16-0180-C; date of approval: August 8, 2016) and Queen’s University (REB #: PAED-406-16; date of approval: September 27, 2016).

Informed consent

Waiver of informed consent was obtained from the University Health Network, Mount Sinai Hospital and Queen’s University REBs.

Supplementary material

296_2019_4293_MOESM1_ESM.tiff (4.4 mb)
Comparing the frequency of study patients (in percentage) classified according to the Villefranche (old) classification and the 2017 International (new) Classification. Analyses in the current study were undertaken according to the current classification. *hcEDS was not used when classifying patients according to the new criteria. **Classic-like Ehlers–Danlos Syndrome (clEDS) is a new diagnosis in the 2017 International Classification. Abbreviations: HSD, hypermobility spectrum disorders. hEDS, hypermobile EDS. hcEDS, overlapping hypermobility and classic EDS. cEDS, classic EDS. clEDS, classical-like EDS, a, arthrochalasia EDS. v, vascular EDS. k, kyphoscoliotic EDS. (TIFF 4546 KB)
296_2019_4293_MOESM2_ESM.docx (17 kb)
Supplementary material 2 (DOCX 17 KB)

References

  1. 1.
    Hakim AJ, Sahota A (2006) Joint hypermobility and skin elasticity: the hereditary disorders of connective tissue. Clin Dermatol 24:521–533.  https://doi.org/10.1016/j.clindermatol.2006.07.013 CrossRefGoogle Scholar
  2. 2.
    Beighton P, De Paepe A, Steinmann B et al (1998) Ehlers–Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers–Danlos National Foundation (USA) and Ehlers–Danlos Support Group (UK). Am J Med Genet 77:31–37CrossRefGoogle Scholar
  3. 3.
    Malfait F, Francomano C, Byers P et al (2017) The 2017 international classification of the Ehlers–Danlos syndromes. Am J Med Genet C Semin Med Genet 175:8–26.  https://doi.org/10.1002/ajmg.c.31552 CrossRefGoogle Scholar
  4. 4.
    Castori M, Tinkle B, Levy H et al (2017) A framework for the classification of joint hypermobility and related conditions. Am J Med Genet C Semin Med Genet 175:148–157.  https://doi.org/10.1002/ajmg.c.31539 CrossRefGoogle Scholar
  5. 5.
    Syx D, De Wandele I, Rombaut L, Malfait F (2017) Hypermobility, the Ehlers–Danlos syndromes and chronic pain. Clin Exp Rheumatol 107:116–122Google Scholar
  6. 6.
    Colombi M, Dordoni C, Chiarelli N, Ritelli M (2015) Differential diagnosis and diagnostic flow chart of joint hypermobility syndrome/Ehlers–Danlos syndrome hypermobility type compared to other heritable connective tissue disorders. Am J Med Genet C Semin Med Genet 169C:6–22.  https://doi.org/10.1002/ajmg.c.31429 CrossRefGoogle Scholar
  7. 7.
    Rodgers KR, Gui J, Dinulos MBP, Chou RC (2017) Ehlers–Danlos syndrome hypermobility type is associated with rheumatic diseases. Sci Rep.  https://doi.org/10.1038/srep39636 Google Scholar
  8. 8.
    Davis NA (2005) Invisible disability. Ethics 116:153–213CrossRefGoogle Scholar
  9. 9.
    Murray B, Yashar BM, Uhlmann WR et al (2013) Ehlers–Danlos syndrome, hypermobility type: A characterization of the patients’ lived experience. Am J Med Genet A 161A:2981–2988.  https://doi.org/10.1002/ajmg.a.36293 CrossRefGoogle Scholar
  10. 10.
    Bulbena A, Gago J, Pailhez G et al (2011) Joint hypermobility syndrome is a risk factor trait for anxiety disorders: a 15-year follow-up cohort study. Gen Hosp Psychiatry 33:363–370.  https://doi.org/10.1016/j.genhosppsych.2011.03.004 CrossRefGoogle Scholar
  11. 11.
    Ghibellini G, Brancati F, Castori M (2015) Neurodevelopmental attributes of joint hypermobility syndrome/Ehlers–Danlos syndrome, hypermobility type: update and perspectives. Am J Med Genet C Semin Med Genet 169C:107–116.  https://doi.org/10.1002/ajmg.c.31424 CrossRefGoogle Scholar
  12. 12.
    Pasquini M, Celletti C, Berardelli I et al (2014) Unexpected association between joint hypermobility syndrome/Ehlers–Danlos syndrome hypermobility type and obsessive-compulsive personality disorder. Rheumatol Int 34:631–636.  https://doi.org/10.1007/s00296-013-2901-2 CrossRefGoogle Scholar
  13. 13.
    Sinibaldi L, Ursini G, Castori M (2015) Psychopathological manifestations of joint hypermobility and joint hypermobility syndrome/Ehlers–Danlos syndrome, hypermobility type: the link between connective tissue and psychological distress revised. Am J Med Genet Part C Semin Med Genet.  https://doi.org/10.1002/ajmg.c.31430 Google Scholar
  14. 14.
    Baeza-Velasco C, Sinibaldi L, Castori M (2018) Attention-deficit/hyperactivity disorder, joint hypermobility-related disorders and pain: expanding body-mind connections to the developmental age. ADHD Atten Deficit Hyperact Disord 10:163–175CrossRefGoogle Scholar
  15. 15.
    Bulbena A, Duro JC, Mateo A et al (1988) Joint hypermobility syndrome and anxiety disorders. Lancet 2:694CrossRefGoogle Scholar
  16. 16.
    Hershenfeld SA, Wasim S, McNiven V et al (2016) Psychiatric disorders in Ehlers–Danlos syndrome are frequent, diverse and strongly associated with pain. Rheumatol Int 36:341–348.  https://doi.org/10.1007/s00296-015-3375-1 CrossRefGoogle Scholar
  17. 17.
    World Health Organization (2004) ICD-10: international statistical classification of diseases and related health problems: tenth revision, 2nd edn. World Health Organization, Geneva. https://www.who.int/iris/handle/10665/42980
  18. 18.
    Bulbena A, Baeza-Velasco C, Bulbena-Cabre A et al (2017) Psychiatric and psychological aspects in the Ehlers–Danlos syndromes. Am J Med Genet C Semin Med Genet 175:237–245.  https://doi.org/10.1002/ajmg.c.31544 CrossRefGoogle Scholar
  19. 19.
    Bulbena A, Baeza-Velasco C, Bulbena-Cabré A et al (2017) Psychiatric and psychological aspects in the Ehlers–Danlos syndromes. Am J Med Genet Part C Semin Med Genet.  https://doi.org/10.1002/ajmg.c.31544 Google Scholar
  20. 20.
    Smith TO, Easton V, Bacon H et al (2014) The relationship between benign joint hypermobility syndrome and psychological distress: a systematic review and meta-analysis. Rheumatology.  https://doi.org/10.1093/rheumatology/ket317 (United Kingdom) Google Scholar
  21. 21.
    Baeza-Velasco C, Pailhez G, Bulbena A, Baghdadli A (2015) Joint hypermobility and the heritable disorders of connective tissue: clinical and empirical evidence of links with psychiatry. Gen Hosp Psychiatry 37:24–30.  https://doi.org/10.1016/j.genhosppsych.2014.10.002 CrossRefGoogle Scholar
  22. 22.
    Berglund B, Pettersson C, Pigg M, Kristiansson P (2015) Self-reported quality of life, anxiety and depression in individuals with Ehlers–Danlos syndrome (EDS): a questionnaire study. BMC Musculoskelet Disord.  https://doi.org/10.1186/s12891-015-0549-7 Google Scholar
  23. 23.
    Cederlof M, Larsson H, Lichtenstein P et al (2016) Nationwide population-based cohort study of psychiatric disorders in individuals with Ehlers–Danlos syndrome or hypermobility syndrome and their siblings. BMC Psychiatry 16:207.  https://doi.org/10.1186/s12888-016-0922-6 CrossRefGoogle Scholar
  24. 24.
    Baeza-Velasco C, Bourdon C, Montalescot L et al (2018) Low- and high-anxious hypermobile Ehlers–Danlos syndrome patients: comparison of psychosocial and health variables. Rheumatol Int.  https://doi.org/10.1007/s00296-018-4003-7 Google Scholar
  25. 25.
    García Campayo J, Asso E, Alda M et al (2010) Association between joint hypermobility syndrome and panic disorder: a case-control study. Psychosomatics.  https://doi.org/10.1176/appi.psy.51.1.55 Google Scholar
  26. 26.
    Baeza-Velasco C, Gély-Nargeot MC, Vilarrasa AB, Bravo JF (2011) Joint hypermobility syndrome: problems that require psychological intervention. Rheumatol Int 31:1131–1136CrossRefGoogle Scholar
  27. 27.
    Bulbena-Cabré A, Rojo C, Pailhez G et al (2018) Joint hypermobility is also associated with anxiety disorders in the elderly population. Int J Geriatr Psychiatry.  https://doi.org/10.1002/gps.4733 Google Scholar
  28. 28.
    Simon V, Czobor P, Balint S et al (2009) Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 194:204–211.  https://doi.org/10.1192/bjp.bp.107.048827 CrossRefGoogle Scholar
  29. 29.
    Harris MJ (1998) ADD/ADHD and hypermobile joints. J Paediatr Child Heal 34:400–401Google Scholar
  30. 30.
    Eksikliği D,, Taner Y et al (2011) Bozukluğu olan Hastalarda Benign Eklem Hipermobilite Sendromu Şebnem KOLDAŞ DOĞAN H. Benign joint hypermobility syndrome in patients with attention deficit/hyperactivity disorders. Turk J Rheumatol.  https://doi.org/10.5152/tjr.2011.029 Google Scholar
  31. 31.
    Shiari R, Saeidifard F, Zahed G (2013) Evaluation of the prevalence of joint laxity in children with attention deficit/hyperactivity disorder. Ann Paediatr Rheumatol 3:78–80CrossRefGoogle Scholar
  32. 32.
    Hollertz O (2012) Searching for a biological marker common for both ADHD and EDS. Lakartidningen 109:41–42Google Scholar
  33. 33.
    Castori M, Dordoni C, Valiante M et al (2014) Nosology and inheritance pattern(s) of joint hypermobility syndrome and Ehlers–Danlos syndrome, hypermobility type: a study of intrafamilial and interfamilial variability in 23 Italian pedigrees. Am J Med Genet Part A.  https://doi.org/10.1002/ajmg.a.36805 Google Scholar
  34. 34.
    Cederlöf M, Larsson H, Lichtenstein P et al (2016) Nationwide population-based cohort study of psychiatric disorders in individuals with Ehlers–Danlos syndrome or hypermobility syndrome and their siblings. BMC Psychiatry.  https://doi.org/10.1186/s12888-016-0922-6 Google Scholar
  35. 35.
    Glans M, Bejerot S, Humble MB (2017) Generalised joint hypermobility and neurodevelopmental traits in a non-clinical adult population. B J Psych Open 3:236–242.  https://doi.org/10.1192/bjpo.bp.116.004325 CrossRefGoogle Scholar
  36. 36.
    Franke B, Neale BM, Faraone SV et al (2009) Genome-wide association studies in ADHD. Hum Genet.  https://doi.org/10.1007/s00439-009-0663-4 Google Scholar
  37. 37.
    Lasky-Su J, Neale BM, Franke B et al (2008) Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet Part B Neuropsychiatr Genet.  https://doi.org/10.1002/ajmg.b.30867 Google Scholar
  38. 38.
    Neale BM, Lasky-Su J, Anney R et al (2008) Genome-wide association scan of attention deficit hyperactivity disorder. Am J Med Genet Part B Neuropsychiatr Genet.  https://doi.org/10.1002/ajmg.b.30866 Google Scholar
  39. 39.
    Lesch KP, Timmesfeld N, Renner TJ et al (2008) Molecular genetics of adult ADHD: Converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm.  https://doi.org/10.1007/s00702-008-0119-3 Google Scholar
  40. 40.
    Bendik EM, Tinkle BT, Al-shuik E et al (2011) Joint hypermobility syndrome: a common clinical disorder associated with migraine in women. Cephalalgia 31:603–613.  https://doi.org/10.1177/0333102410392606 CrossRefGoogle Scholar
  41. 41.
    Breslau N, Davis GC (1992) Migraine, major depression and panic disorder: a prospective epidemiologic study of young adults. Cephalalgia 12:85–90.  https://doi.org/10.1046/j.1468-2982.1992.1202085.x CrossRefGoogle Scholar
  42. 42.
    Cazzato D, Castori M, Lombardi R et al (2016) Small fiber neuropathy is a common feature of Ehlers–Danlos syndromes. Neurology.  https://doi.org/10.1212/WNL.0000000000002847 Google Scholar
  43. 43.
    Baeza-Velasco C, Bulbena A, Polanco-Carrasco R, Jaussaud R (2018) Cognitive, emotional, and behavioral considerations for chronic pain management in the Ehlers–Danlos syndrome hypermobility-type: a narrative review. Disabil Rehabil.  https://doi.org/10.1080/09638288.2017.1419294 Google Scholar
  44. 44.
    Wiech K, Tracey I (2009) The influence of negative emotions on pain: behavioral effects and neural mechanisms. Neuroimage 47:987–994CrossRefGoogle Scholar
  45. 45.
    Linton SJ (1985) The relationship between activity and chronic back pain. Pain.  https://doi.org/10.1016/0304-3959(85)90092-2 Google Scholar
  46. 46.
    Levy RL, Olden KW, Naliboff BD et al (2006) Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 130:1447–1458.  https://doi.org/10.1053/j.gastro.2005.11.057 CrossRefGoogle Scholar
  47. 47.
    Whitehead WE, Palsson O, Jones KR (2002) Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 122:1140–1156CrossRefGoogle Scholar
  48. 48.
    Berglund B, Anne-Cathrine M, Randers I (2010) Dignity not fully upheld when seeking health care: Experiences expressed by individuals suffering from Ehlers–Danlos syndrome. Disabil Rehabil.  https://doi.org/10.3109/09638280903178407 Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Fred A. Litwin Family Centre in Genetic MedicineUniversity Health Network and Mount Sinai HospitalTorontoCanada
  2. 2.Department of Pediatrics, Division of Medical GeneticsQueen’s UniversityKingstonCanada
  3. 3.Centre for Addiction and Mental HealthTorontoCanada
  4. 4.Departments of Medicine, Psychiatry, and Laboratory Medicine and PathobiologyUniversity of TorontoTorontoCanada

Personalised recommendations